Array-Based Comparative Genomic Hybridization Characterizes a Deletion Associated With a t(15;17) in Acute Promyelocytic Leukemia

被引:6
作者
Dolan, Michelle [1 ]
Peterson, Bruce [2 ]
Hirsch, Betsy [1 ]
机构
[1] Univ Minnesota, Sch Med, Cytogenet Lab, Dept Lab Med, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Dept Pathol & Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
关键词
Clinical pathology; Hematopathology; Genetics;
D O I
10.1309/AJCPENMUI47OGKRW
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The majority of de novo leukemias are characterized by well-known recurring translocations or inversions. In approximately 2% to 20% of these cases, deletions accompany these rearrangements. Because such deletions are undetectable by G-banding, aberrant fluorescence in situ hybridization (FISH) signal patterns are often the only indication of their presence. Array-based comparative genomic hybridization (a-CGH) permits examination of the entire genome at a resolution unattainable by G-banding or FISH. We present a case of a deletion of the derivative chromosome 17 of a t(15;17) in acute promyelocytic leukemia, the size and gene content Of which were characterized by a-CGH. We hypothesize that this patient's more aggressive disease course is due to loss of one or more of these genes. Such submicroscopic deletions involving the t(15;17) have only rarely been reported, and, to our knowledge, this is the first case in which a-CGH has been applied to its characterization.
引用
收藏
页码:818 / 823
页数:6
相关论文
共 34 条
  • [1] [Anonymous], 2005, ISCN (2005): An International System for Human Nomenclature
  • [2] Bacher U, 2005, HAEMATOLOGICA, V90, P558
  • [3] Human replication protein Cdc6 prevents mitosis through a checkpoint mechanism that implicates Chk1
    Clay-Farrace, L
    Pelizon, C
    Santamaria, D
    Pines, J
    Laskey, RA
    [J]. EMBO JOURNAL, 2003, 22 (03) : 704 - 712
  • [4] A HUMAN C-ERBA ONCOGENE HOMOLOG IS CLOSELY PROXIMAL TO THE CHROMOSOME 17 BREAKPOINT IN ACUTE PROMYELOCYTIC LEUKEMIA
    DAYTON, AI
    SELDEN, JR
    LAWS, G
    DORNEY, DJ
    FINAN, J
    TRIPPUTI, P
    EMANUEL, BS
    ROVERA, G
    NOWELL, PC
    CROCE, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (14): : 4495 - 4499
  • [5] Clinical implications of der(9q) deletions detected through dual-fusion fluorescence in situ hybridization in patients with chronic myeloid leukemia
    de Campos, Mireille Guimaraes Vaz
    Tadeu Montesano, Fabio
    Madalena Rodrigues, Maria
    Ferrari Chauffaille, Maria de Lourdes Lopes
    [J]. CANCER GENETICS AND CYTOGENETICS, 2007, 178 (01) : 49 - 56
  • [6] Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy
    Dewald, GW
    Wyatt, WA
    Silver, RT
    [J]. LEUKEMIA & LYMPHOMA, 1999, 34 (5-6) : 481 - +
  • [7] Deletion of the multidrug resistance-associated protein (MRP1) gene in acute myeloid leukemia with inversion of chromosome 16 has no prognostic impact
    Döhner, K
    Schlenk, RF
    van der Reijden, BA
    Döhner, H
    [J]. LEUKEMIA, 2000, 14 (06) : 1154 - 1154
  • [8] Deletion size characterization of der(9) deletions in Philadelphia-positive chronic myeloid leukemia
    Douet-Guilbert, Nathalie
    Morel, Frederic
    Quemener, Sylvia
    Maguer, Aurelie
    Le Bris, Marie-Josee
    Morice, Patrick
    Berthou, Christian
    De Braekeleer, Marc
    [J]. CANCER GENETICS AND CYTOGENETICS, 2006, 170 (02) : 89 - 92
  • [9] Deletion of BCR region 3′ in chronic myelogenous leukemia
    González, FA
    Anguita, E
    Mora, A
    Asenjo, S
    López, I
    Polo, M
    Villegas, A
    [J]. CANCER GENETICS AND CYTOGENETICS, 2001, 130 (01) : 68 - 74
  • [10] Thyroid hormone receptors/THR genes in human cancer
    González-Sancho, JM
    García, V
    Bonilla, M
    Muñoz, A
    [J]. CANCER LETTERS, 2003, 192 (02) : 121 - 132